Equivalence of conventionally-derived and parthenote-derived human embryonic stem cells

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Harness, Julie V ^a   Turovets, Nikolay A ^b   Seiler, Magdalene J ^a   Nistor, Gabriel ^a   Altun, Gulsah ^c   Agapova, Larissa S ^b   Ferguson, David ^a   Laurent, Louise C ^c   Loring, Jeanne F ^c   Keirstead, Hans S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INTERNATIONAL STEM CELL CORPORATION   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCLEROPROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; EMBRYONIC STEM CELL; EPIGENETICS; GENE EXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NEURAL STEM CELL; PIGMENT EPITHELIUM; COMPARATIVE STUDY; CYTOLOGY; GENETICS; NERVE CELL; PARTHENOGENESIS;

CELL DIFFERENTIATION; CELL PROLIFERATION; DNA METHYLATION; EMBRYONIC STEM CELLS; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; HUMANS; NEURAL STEM CELLS; NEURONS; PARTHENOGENESIS;

EID: 79251575001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014499     Document Type: Article

References (23)

1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147.
2. Klimanskaya I, Chung Y, Becker S, Lu SJ, Lanza R (2006) Human embryonic stem cell lines derived from single blastomeres. Nature 444: 481-485.
3. Revazova ES, Turovets NA, Kochetkova OD, Kindarova LB, Kuzmichev LN, et al. (2007) Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 9: 432-449.
4. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
5. Busch C, Bareiss PM, Sinnberg T, Just L, Wehrmann M, et al. (2009) Isolation of three stem cell lines from human sacrococcygeal teratomas. J Pathol 217: 589-596.
6. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
7. Revazova ES, Turovets NA, Kochetkova OD, Agapova LS, Sebastian JL, et al. (2008) HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 10: 11-24.
8. Lin G, OuYang Q, Zhou X, Gu Y, Yuan D, et al. (2007) A highly homozygous and parthenogenetic human embryonic stem cell line derived from a onepronuclear oocyte following in vitro fertilization procedure. Cell Res 17: 999-1007.
9. Mai Q, Yu Y, Li T, Wang L, Chen MJ, et al. (2007) Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res 17: 1008-1019.
10. Klimanskaya I, Hipp J, Rezai KA, West M, Atala A, et al. (2004) Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 6: 217-245.
11. Grisanti S, Guidry C (1995) Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 36: 391-405.
12. Opas M, Dziak E (1994) bFGF-induced transdifferentiation of RPE to neuronal progenitors is regulated by the mechanical properties of the substratum. Dev Biol 161: 440-454.
13. Zhao S, Rizzolo LJ, Barnstable CJ (1997) Differentiation and transdifferentiation of the retinal pigment epithelium. Int Rev Cytol 171: 225-266.
14. Burke JM, Skumatz CM, Irving PE, McKay BS (1996) Phenotypic heterogeneity of retinal pigment epithelial cells in vitro and in situ. Exp Eye Res 62: 63-73.
15. Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hinman CR, et al. (2009) Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 27: 2427-2434.
16. Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, et al. (2004) Human embryonic stem cells possess immune-privileged properties. Stem Cells 22: 448-456.
17. Ponsioen TL, van Luyn MJ, van der Worp RJ, van Meurs JC, Hooymans JM, et al. (2008) Collagen distribution in the human vitreoretinal interface. Invest Ophthalmol Vis Sci 49: 4089-4095.
18. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G (1996) Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544-1550.
19. Fernandez CA, Butterfield C, Jackson G, Moses MA (2003) Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor. J Biol Chem 278: 40989-40995.
20. Kiselyov VV, Soroka V, Berezin V, Bock E (2005) Structural biology of NCAM homophilic binding and activation of FGFR. J Neurochem 94: 1169-1179.
21. Krieglstein K, Reuss B, Maysinger D, Unsicker K (1998) Short communication: transforming growth factor-beta mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons. Eur J Neurosci 10: 2746-2750.
22. Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, et al. (2006) Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24: 221-229.
23. Menendez P, Bueno C, Wang L, Bhatia M (2005) Human embryonic stem cells: potential tool for achieving immunotolerance? Stem Cell Rev 1: 151-158.